<DOC>
	<DOCNO>NCT02326376</DOCNO>
	<brief_summary>A non-interventional , post authorization safety study evaluate safety Kineret treatment Cryopyrin Associated Periodic Syndromes ( CAPS ) routine clinical care regard serious infection , malignancy , injection site reaction , allergic reaction medication error , include re-use syringe .</brief_summary>
	<brief_title>Kineret CAPS Post Authorisation Study</brief_title>
	<detailed_description />
	<mesh_term>Cryopyrin-Associated Periodic Syndromes</mesh_term>
	<mesh_term>Interleukin 1 Receptor Antagonist Protein</mesh_term>
	<criteria>Informed consent patient and/or caregiver Kineret treatment accord Summary Product Characteristics ( SmPC ) , confirm Investigator</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>